The report provides a detailed analysis essential for establishing an Olanzapine (Zyprexa) production plant. It encompasses all critical aspects necessary for Olanzapine (Zyprexa) production, including the cost of Olanzapine (Zyprexa) production, Olanzapine (Zyprexa) plant cost, Olanzapine (Zyprexa) production costs, and the overall Olanzapine (Zyprexa) production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Olanzapine (Zyprexa) production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Olanzapine (Zyprexa) is a generic name for a famous medication that is widely used in the pharmaceutical industry. This drug is extensively utilized for the treatment of schizophrenia and in managing its symptoms, such as hallucinations and delusions. Moreover, it also finds its application in the treatment of bipolar disorder, which includes manic or mixed episodes, and also prevents its recurrence. Additionally, it is often used in combination with other drugs for treatment-resistant depression to manage severe psychotic symptoms. Additionally, this drug is also employed in clinical trials to study its safety and effectiveness in treating several psychiatric and neurological disorders.
The market for Olanzapine (Zyprexa) is primarily led by its wide usage as a second-generation antipsychotic agent for the treatment of schizophrenia and bipolar illness, which remarkably boosts its demand in the medical industry. Moreover, its employment as a medication for the treatment of moderate to severe manic episodes in patients with bipolar disorder and other psychiatric conditions significantly amplifies its demand in the medical and pharmaceutical industries. Additionally, its usage in the treatment and managing the symptoms of various mental health disorders further enhances its market expansion.
Its utilization in the development of new drugs and research activities and understanding its interaction with other medications further promotes its demand in the biotechnology and research & development industries. Furthermore, several factors such as the source and purity, cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc., largely influence industrial Olanzapine (Zyprexa) procurement globally.
Raw Material for Olanzapine (Zyprexa) Production
According to the Olanzapine production plant project report, the major raw materials for Olanzapine production include Sulfur-Propanol-DMF-Trimethylamine-Malonitrile-2-fluoronitrobenzene-Sodium Hydride-Anhydrous Stannous Chloride - 1-Methylpiperazine.
Production Process of Olanzapine (Zyprexa)
The extensive Olanzapine production cost report consists of the following industrial production process:
- Production from DMF: The production process is initiated by the reaction of a combination of sulfur, propanol, DMF, and trimethylamine, followed by heating while adding manlonitrile to form 2-amino-5-methylthiophene3-carbinitrile. Further, the obtained compound is reacted with 2-fluoronitrobenzene and sodium hydride to give 2-(2-nitroanilino)-5-methylthiophene3-carbinitrile, followed by a reaction with anhydrous stannous chloride to close the diazepine ring. Further, the obtained diazepine is reacted with 1-methylpiperazine in DMSO to synthesize Olanzapine as the final product.
Olanzapine is a form of synthetic derivative of thienobenzodiazepine with antipsychotic and antinausea action. The molecular formula of the compound is C17H20N4S, and its molar mass is 312.4 g/mol. This drug is also known by the names Zolafren, Olanzapine pamoate, and Zyprexa. It appears as a yellow-colored crystalline solid that is not soluble in water. Moreover, the melting point of the compound is 189-195 ºC, and its boiling point is 476 ºC. The IUPAC name of the compound is 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine. It releases toxic fumes of nitrogen oxides and sulfur oxides when it decomposes on heating. It is administered orally and intramuscularly for the treatment of psychiatric disorders.
